title: Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
authors.affiliation: School of Population Health, University of Queensland, Brisbane, QLD 4006, Australia. Electronic address: m.jones@sph.uq.edu.au.
authors.forename: Mark
authors.initials: M
authors.lastname: Jones
authors.affiliation: Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, Australia.
authors.forename: Chris
authors.initials: C
authors.lastname: Del Mar
authors.affiliation: Japan Institute of Pharmacovigilance, Osaka, Japan.
authors.forename: Rokuro
authors.initials: R
authors.lastname: Hama
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy*; D008297:Male; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir / Q000627:therapeutic use*; D058873:Pandemics; D053243:Zanamivir / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir